NCNAMICRO

NuCana plc

HealthcareBiotechnology
$1.58
$0.00(+1.94%)
52W$1.33
$25.58
Updated Jun 30, 02:00 AM
RSI31
RS Rating9/99
Beta2.22
Volatility111%
F-Score3/9
Mkt Cap$10M
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

NuCana plc is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 9), showing significant lag compared to the market leaders. Earnings growth of 99% provides fundamental context to the price action. Investors should exercise caution due to high volatility (111% annualized), which requires wider risk management.

Relative Strength
9
out of 99
Lagging
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
2.22
vs S&P 500
HIGH BETA
52W Position
1%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$2.02
50 SMA > 100 SMA$1.99
100 SMA > 150 SMA$2.50
150 SMA > 200 SMA$2.95

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$1.88-15.73%BELOW
50 SMA$2.02-21.69%BELOW
100 SMA$1.99-20.52%BELOW
150 SMA$2.50-36.83%BELOW
200 SMA$2.95-46.52%BELOW

Price Performance

1D+1.9%
1W-13.7%
1M-32.2%
3M+17.9%
6M-54.3%
YTD-56.6%
1Y-86.2%
3Y-92.8%
52-Week Trading Range1% from low
$1.58
52W Low$1.33
52W High$25.58

Technical Indicators

RSI (14)BEARISH
31.1
305070
Setup ScoreCOOL
2/10
Base depth: 61.2%

Risk Profile

Beta
2.22
52W Vol
111%
ATR
$0.15
Max DD (1Y)
-92%

Volume Analysis

Today
41.6K
50D Avg
39.0K
Vol Ratio
1.07x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25-167%
$-4.00
Q3'25+91%
$-0.07
Q4'25-450%
$-0.66
Q1'26+99%
$-1.07
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth

10 Years:-16.05%
5 Years:
3 Years:
TTM:+94.34%

Stock Price CAGR

10 Years:-66.18%
5 Years:-83.75%
3 Years:-92.75%
1 Year:-86.24%

Return on Equity

10Y Avg:-73.4%
5Y Avg:-118.1%
3Y Avg:-159.9%
Last Year:-154.2%

Key Metrics

Market Cap$10M
Gross Margin
Net Margin
Piotroski F-Score3/9

Frequently Asked Questions

Is NCNA in an uptrend right now?

NCNA has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is NCNA overbought or oversold?

NCNA's RSI (14) is 31. The stock is in neutral territory, neither overbought nor oversold.

Is NCNA outperforming the market?

NCNA has a Relative Strength (RS) Rating of 9 out of 99. NCNA is currently lagging the broader market.

Where is NCNA in its 52-week range?

NCNA is trading at $1.58, which is 6% of its 52-week high ($25.58) and 1% above its 52-week low ($1.33).

How volatile is NCNA?

NCNA has a Beta of 2.22 and 52-week volatility of 111%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.